3,464
Views
14
CrossRef citations to date
0
Altmetric
Reviews

Evidence update: GlaxoSmithKline’s inactivated quadrivalent influenza vaccines

, , , &
Pages 201-214 | Received 09 Sep 2015, Accepted 26 Oct 2015, Published online: 05 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sevim Meşe, Aysun Uyanik, Alev Özakay, Serdar Öztürk & Selim Badur. (2018) Influenza surveillance in Western Turkey in the era of quadrivalent vaccines: A 2003–2016 retrospective analysis. Human Vaccines & Immunotherapeutics 14:8, pages 1899-1908.
Read now
Riju Ray, Gaël Dos Santos, Philip O. Buck, Carine Claeys, Gonçalo Matias, Bruce L. Innis & Rafik Bekkat-Berkani. (2017) A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control. Human Vaccines & Immunotherapeutics 13:7, pages 1640-1652.
Read now

Articles from other publishers (12)

Dipanshi Gupta & Sumedha Mohan. (2023) Influenza vaccine: a review on current scenario and future prospects. Journal of Genetic Engineering and Biotechnology 21:1.
Crossref
Li Li, Ze-Lin Yan, Lei Luo, Wenhui Liu, Zhou Yang, Chen Shi, Bo-Wen Ming, Jun Yang, Peihua Cao & Chun-Quan Ou. (2023) Influenza-Associated Excess Mortality by Age, Sex, and Subtype/Lineage: Population-Based Time-Series Study With a Distributed-Lag Nonlinear Model. JMIR Public Health and Surveillance 9, pages e42530.
Crossref
Rina Fajri Nuwarda, Abdulsalam Abdullah Alharbi & Veysel Kayser. (2021) An Overview of Influenza Viruses and Vaccines. Vaccines 9:9, pages 1032.
Crossref
Jidang Chen, Jiehuang Wang, Jipei Zhang & Hinh Ly. (2021) Advances in Development and Application of Influenza Vaccines. Frontiers in Immunology 12.
Crossref
Maria Montes de Oca. (2020) Smoking Cessation/Vaccinations. Clinics in Chest Medicine 41:3, pages 495-512.
Crossref
Angela Choi, Badiaa Bouzya, Klaus-Daniel Cortés Franco, Daniel Stadlbauer, Arvind Rajabhathor, Ronan N. Rouxel, Roland Mainil, Marie Van der Wielen, Peter Palese, Adolfo García-Sastre, Bruce L. Innis, Florian Krammer, Michael Schotsaert, Corey P. Mallett & Raffael Nachbagauer. (2019) Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice. ImmunoHorizons 3:4, pages 133-148.
Crossref
José Antonio López Trigo, Rosa López Mongil, Alberto Mariano Lázaro, Gloria Mato Chaín, Norberto Moreno Villajos & Primitivo Ramos Cordero. (2018) Vacunación frente a la gripe estacional en las personas mayores. Evaluación de la vacuna tetravalente. Informe de posicionamiento. Revista Española de Geriatría y Gerontología 53, pages 185-202.
Crossref
Ji Yun Noh, Won Suk Choi, Joon Young Song, Han Sol Lee, Sooyeon Lim, Jacob Lee, Yu Bin Seo, Jin-Soo Lee, Seong-Heon Wie, Hye Won Jeong, Jung Yeon Heo, Young Keun Kim, Kyung Hwa Park, Shin Woo Kim, Sun Hee Lee, Jung Hwa Lee, Dong Hyun Kim, Sung Il Woo, Chae Seung Lim, Kyung Soon Cho, Hee Jin Cheong & Woo Joo Kim. (2018) Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007–2014. Vaccine 36:35, pages 5304-5308.
Crossref
Dominic Thorrington, Edwin van Leeuwen, Mary Ramsay, Richard Pebody & Marc Baguelin. (2017) Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England. BMC Medicine 15:1.
Crossref
Rafik Bekkat-Berkani, Tom Wilkinson, Philippe Buchy, Gael Dos Santos, Dimitris Stefanidis, Jeanne-Marie Devaster & Nadia Meyer. (2017) Seasonal influenza vaccination in patients with COPD: a systematic literature review. BMC Pulmonary Medicine 17:1.
Crossref
Jan F. Mieves, Kirsten Wittke, Helma Freitag, Hans-Dieter Volk, Carmen Scheibenbogen & Leif G. Hanitsch. (2017) Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID). Current Allergy and Asthma Reports 17:11.
Crossref
Christiaan Dolk, Martin Eichner, Robert Welte, Anastassia Anastassopoulou, Laure-Anne Van Bellinghen, Barbara Poulsen Nautrup, Ilse Van Vlaenderen, Ruprecht Schmidt-Ott, Markus Schwehm & Maarten Postma. (2016) Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model. PharmacoEconomics 34:12, pages 1299-1308.
Crossref